Want to see HK:0919 full AI Analyst Report?
Top Page
Modern Healthcare Technology Holdings Limited
(0919)
Select Model
Select Model
Rating:50Neutral
Price Target:
HK$0.08
▲(3.75% Upside)
Action:Reiterated
Date:08/05/26
The score is anchored by solid cash generation and improved leverage, but capped by ongoing net losses, negative ROE, and lack of revenue growth. Technicals add further pressure with price below key moving averages and negative MACD, while valuation is constrained by a negative P/E and no dividend yield data.
Positive Factors
Cash generation
Consistent positive operating cash flow and free cash flow across FY2023–FY2026 indicate the company generates cash despite accounting losses. Durable cash conversion reduces dependence on external financing, funds operations and investment, and supports deleveraging and strategic flexibility over the medium term.
Negative Factors
Persistent net losses & negative ROE
Multi-year net losses and a negative return on equity signal the business has not produced shareholder returns. Persistent losses erode capital efficiency, constrain reinvestment, increase financing costs, and make it harder to justify the equity base unless profitability turns sustainably positive.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Consistent positive operating cash flow and free cash flow across FY2023–FY2026 indicate the company generates cash despite accounting losses. Durable cash conversion reduces dependence on external financing, funds operations and investment, and supports deleveraging and strategic flexibility over the medium term.
Read all positive factors
Modern Healthcare Technology Holdings Limited (0919) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$70.55M
Dividend Yield6.43%
Average Volume (3M)230.80K
Price to Earnings (P/E)―
Beta (1Y)-0.11
Revenue Growth-2.31%
EPS Growth66.07%
CountryHK
Employees783
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding904,483,950
10 Day Avg. Volume47,600
30 Day Avg. Volume230,800
Financial Highlights & Ratios
PEG Ratio0.72
Price to Book (P/B)0.45
Price to Sales (P/S)0.19
P/FCF Ratio1.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model
Company Description
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Ski...
How the Company Makes Money
null...
Modern Healthcare Technology Holdings Limited Financial Statement Overview
Summary
Income Statement
41
Neutral
Balance Sheet
62
Positive
Cash Flow
67
Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 442.81M | 453.27M | 454.71M | 406.33M | 355.59M |
| Gross Profit | 91.89M | 165.26M | 166.96M | 394.72M | 341.52M |
| EBITDA | 108.17M | 77.11M | 95.68M | 70.72M | 26.39M |
| Net Income | -1.76M | -5.07M | -9.57M | -20.61M | -68.81M |
Balance Sheet | |||||
| Total Assets | 521.38M | 564.46M | 611.04M | 561.35M | 570.96M |
| Cash, Cash Equivalents and Short-Term Investments | 305.63M | 236.67M | 193.66M | 177.53M | 127.53M |
| Total Debt | 43.50M | 68.65M | 106.57M | 40.11M | 65.01M |
| Total Liabilities | 328.34M | 373.26M | 416.65M | 357.47M | 347.75M |
| Stockholders Equity | 186.68M | 185.85M | 189.33M | 199.77M | 219.58M |
Cash Flow | |||||
| Free Cash Flow | 77.06M | 134.94M | 64.08M | 125.52M | -29.55M |
| Operating Cash Flow | 80.12M | 151.09M | 78.66M | 139.82M | 51.31M |
| Investing Cash Flow | 5.57M | -50.50M | 8.16M | -13.17M | -79.96M |
| Financing Cash Flow | -62.31M | -66.24M | -70.60M | -77.31M | -78.46M |
Modern Healthcare Technology Holdings Limited Technical Analysis
Neutral
0.08
Price Trends
0.08
Negative
0.09
Negative
0.09
Negative
Market Momentum
>-0.01
Negative
47.80
Neutral
58.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Neutral. The current price of 0.08 is above the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.09, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.80 is Neutral, neither overbought nor oversold. The STOCH value of 58.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0919.
Modern Healthcare Technology Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.65B | 9.21 | 43.78% | 11.19% | -14.68% | -13.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$6.03B | 14.13 | 6.50% | 20.98% | ― | ― | |
57 Neutral | HK$1.82B | 50.35 | 6.47% | ― | 2.78% | -41.23% | |
50 Neutral | HK$70.55M | -39.00 | -0.93% | 6.43% | -2.31% | 66.07% | |
49 Neutral | HK$132.80M | -14.69 | -61.33% | 3.14% | -38.43% | -394.12% | |
43 Neutral | HK$14.18M | -0.72 | -14.87% | ― | -26.00% | -188.55% |
* Consumer Cyclical Sector Average
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
>-0.01
-5.81%
HK:1448
Fu Shou Yuan International Group
2.64
-0.26
-8.84%
HK:1830
Perfect Medical Health Management Limited
1.30
-0.11
-7.93%
HK:8296
Sino-Life Group Limited
0.15
-0.29
-65.91%
HK:8483
Max Sight Group Holdings Limited
0.19
0.08
75.45%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.95
0.63
195.31%
Modern Healthcare Technology Holdings Limited Corporate Events
Modern Healthcare Technology Sets 2026 AGM to Approve Accounts, Board and Share Mandate
Jul 27, 2026
Modern Healthcare Technology Holdings Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates in the healthcare technology space and delivers health-focused products and services. Its corporate governance r...
Modern Healthcare Technology Plans Governance Overhaul to Embrace Electronic and Uncertificated Securities
Jul 24, 2026
Modern Healthcare Technology Holdings Limited plans to update its amended and restated articles of association to align with the latest regulatory requirements in Hong Kong and the Cayman Islands. The proposed new articles will address electronic ...
Modern Healthcare Technology narrows annual loss as operating profit improves
Jun 30, 2026
Modern Healthcare Technology Holdings Limited reported revenue of HK$442.8 million for the year ended 31 March 2026, a slight decline from HK$453.3 million a year earlier. Despite lower revenue and reduced other income, tighter control of operatin...
Modern Healthcare Technology Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend
Jun 5, 2026
Modern Healthcare Technology Holdings Limited has scheduled a board meeting in Hong Kong on 30 June 2026 to approve its annual results for the financial year ended 31 March 2026. The board will also consider the declaration of a dividend, signalin...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.